v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Jul. 31, 2025
Apr. 30, 2025
Current assets:    
Cash $ 2,422 $ 1,493
Inventory 7,599 7,599
Total current assets 10,021 9,092
Total assets 10,021 9,092
Current liabilities:    
Accounts payable and accrued expense 206,213 172,082
Accrued licenses agreement payable 37,500 25,000
Accrued interest and fees payable 227,238 220,521
Convertible notes payable, net of discount 215,391 185,762
Derivative liability 36,974 31,866
Payables - related parties 838,708 747,208
Customer deposits 40,375 40,375
Stock payable 24,000 24,000
Notes payable 511,288 476,312
Note payable- related party 171,892 161,092
Total current liabilities 2,309,579 2,084,218
Total liabilities 2,309,579 2,084,218
Commitments and Contingencies 0 0
Stockholders' deficit:    
Common stock, $0.0001 par value; 600,000,000 shares authorized, 35,776,558 and 34,147,881 shares issued and outstanding, respectively 3,579 3,416
Additional paid-in capital 16,343,852 16,324,169
Accumulated deficit (18,271,717) (18,042,197)
Total (1,923,913) (1,714,249)
Non-controlling interest (375,645) (360,877)
Total stockholders' deficit (2,299,558) (2,075,126)
Total liabilities and stockholders' deficit 10,021 9,092
Series A Preferred Stock    
Stockholders' deficit:    
Preferred stock value 253 253
Series B Preferred Stock    
Stockholders' deficit:    
Preferred stock value 120 110
Series D Preferred Stock    
Stockholders' deficit:    
Preferred stock value $ 0 $ 0